Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)
The PBAC Guidelines explain in detail how to prepare a submission to list a new medicine or medicinal product on the Pharmaceutical Benefits Schedule (ie for public funding). The guidelines provide detailed instructions on what information is required by the PBAC and the Economic Sub-Committee (ESC) to support a proposed new medicine, and the most appropriate form of clinical evidence and economic evaluation for specific submissions.
For information on processes, procedures, timelines and documents required, refer to the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.
Submission structure for submissions requiring evaluation
Enquiries about PBAC submissions can be mailed or emailed to the Pharmaceutical Evaluation Branch at the following address:
Pharmaceutical Evaluation Branch
Department of Health
GPO Box 9848
Canberra ACT 2601